Article

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy Signature

2023-11-25

Abstract excerpt

The distinction between benign and malignant breast tumors is a challenge in clinical settings. While omic studies have contributed to discovering genetic and proteomic signatures in breast cancer, the molecular differences between benign and malignant tumors remain less studied. This pilot study aimed to investigate proteomic differences between both type of tumors to identify protein signatures indicative of mal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8fe592fa-b0c2-55c3-898a-afb7107b5165
DOI: 10.21203/rs.3.rs-3622132/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy SignatureDOI 10.21203/rs.3.rs-3622132/v1Read

Proteomic Analysis of Breast Cancer Subtypes Identifies Stromal Protein Profiles that Contribute to Aggressive Malignant BehaviorSemantic proximity Read

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomesSemantic proximity Read

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read

Breast cancer classification based on proteotypes obtained by SWATH mass spectrometrySemantic proximity Read

Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancersSemantic proximity Read

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.Semantic proximity Read

“A Proteogenomic workflow reveals distinct molecular phenotypes related to breast cancer appearance”Semantic proximity Read

Breast cancer proteomics: a review for cliniciansSemantic proximity Read

Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance.Semantic proximity Read

Correlation Analysis of Histopathology and Proteogenomics Data for Breast CancerSemantic proximity Read

Proteomic analysis in human breast cancer: Identification of a characteristic protein expression profile of malignant breast epitheliumSemantic proximity Read

Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniquesSemantic proximity Read